.... The plasma of patients receiving diphenylhydantoin was found to inhibit the pentose phosphate pathway of the leucocytes. 5 3 2009 © 1971 S. Karger AG, Basel 1971 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...

...P.C. Huijgens; L.G. Thijs; G.J. den Ottolander A patient taking diphenylhydantoin for 3 weeks developed a generalized skin rash, lymphadenopathy and pure red cell aplasia. After withdrawal of the pharmacon all symptoms disappeared spontaneously. Skin rash is a well-known complication...

... with diphenylhydantoin. In thalassemic heterozygotes who develop anemia, the possibility of a megaloblastic pathogenesis should be pursued even when the RBC indices maintain their microcytic-hypochromic expression. 25 11 1986 9 01 1987 25 2 2009 © 1987 S. Karger AG, Basel 1987 Copyright / Drug...